BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 36232630)

  • 1. Damaged DNA Is an Early Event of Neurodegeneration in Induced Pluripotent Stem Cell-Derived Motoneurons with UBQLN2
    Zhang Y; Zeng B; Gu A; Kang Q; Zhao M; Peng G; Zhou M; Liu W; Liu M; Ding L; Liang D; Liu X; Liu M
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232630
    [No Abstract]   [Full Text] [Related]  

  • 2. Amyotrophic lateral sclerosis (ALS) linked mutation in Ubiquilin 2 affects stress granule assembly via TIA-1.
    Peng G; Gu A; Niu H; Chen L; Chen Y; Zhou M; Zhang Y; Liu J; Cai L; Liang D; Liu X; Liu M
    CNS Neurosci Ther; 2022 Jan; 28(1):105-115. PubMed ID: 34750982
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neuronal Expression of UBQLN2
    Picher-Martel V; Renaud L; Bareil C; Julien JP
    Mol Neurobiol; 2019 Jul; 56(7):4680-4696. PubMed ID: 30377984
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALS-linked mutations impair UBQLN2 stress-induced biomolecular condensate assembly in cells.
    Riley JF; Fioramonti PJ; Rusnock AK; Hehnly H; Castañeda CA
    J Neurochem; 2021 Oct; 159(1):145-155. PubMed ID: 34129687
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human Ubiquilin 2 and TDP-43 copathology drives neurodegeneration in transgenic Caenorhabditis elegans.
    Saxton AD; Kraemer BC
    G3 (Bethesda); 2021 Aug; 11(8):. PubMed ID: 33963840
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Key role of UBQLN2 in pathogenesis of amyotrophic lateral sclerosis and frontotemporal dementia.
    Renaud L; Picher-Martel V; Codron P; Julien JP
    Acta Neuropathol Commun; 2019 Jul; 7(1):103. PubMed ID: 31319884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutant UBQLN2
    Chen T; Huang B; Shi X; Gao L; Huang C
    Acta Neuropathol Commun; 2018 Nov; 6(1):122. PubMed ID: 30409191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Axon guidance genes modulate neurotoxicity of ALS-associated UBQLN2.
    Kim SH; Nichols KD; Anderson EN; Liu Y; Ramesh N; Jia W; Kuerbis CJ; Scalf M; Smith LM; Pandey UB; Tibbetts RS
    Elife; 2023 Apr; 12():. PubMed ID: 37039476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALS/FTD mutations in UBQLN2 impede autophagy by reducing autophagosome acidification through loss of function.
    Wu JJ; Cai A; Greenslade JE; Higgins NR; Fan C; Le NTT; Tatman M; Whiteley AM; Prado MA; Dieriks BV; Curtis MA; Shaw CE; Siddique T; Faull RLM; Scotter EL; Finley D; Monteiro MJ
    Proc Natl Acad Sci U S A; 2020 Jun; 117(26):15230-15241. PubMed ID: 32513711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Modeling UBQLN2-mediated neurodegenerative disease in mice: Shared and divergent properties of wild type and mutant UBQLN2 in phase separation, subcellular localization, altered proteostasis pathways, and selective cytotoxicity.
    Sharkey LM; Sandoval-Pistorius SS; Moore SJ; Gerson JE; Komlo R; Fischer S; Negron-Rios KY; Crowley EV; Padron F; Patel R; Murphy GG; Paulson HL
    Neurobiol Dis; 2020 Sep; 143():105016. PubMed ID: 32653673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serpin neuropathology in the P497S UBQLN2 mouse model of ALS/FTD.
    Higgins NR; Greenslade JE; Wu JJ; Miranda E; Galliciotti G; Monteiro MJ
    Brain Pathol; 2021 Sep; 31(5):e12948. PubMed ID: 33780087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Viral expression of ALS-linked ubiquilin-2 mutants causes inclusion pathology and behavioral deficits in mice.
    Ceballos-Diaz C; Rosario AM; Park HJ; Chakrabarty P; Sacino A; Cruz PE; Siemienski Z; Lara N; Moran C; Ravelo N; Golde TE; McFarland NR
    Mol Neurodegener; 2015 Jul; 10():25. PubMed ID: 26152284
    [TBL] [Abstract][Full Text] [Related]  

  • 13. UBQLN2-HSP70 axis reduces poly-Gly-Ala aggregates and alleviates behavioral defects in the C9ORF72 animal model.
    Zhang K; Wang A; Zhong K; Qi S; Wei C; Shu X; Tu WY; Xu W; Xia C; Xiao Y; Chen A; Bai L; Zhang J; Luo B; Wang W; Shen C
    Neuron; 2021 Jun; 109(12):1949-1962.e6. PubMed ID: 33991504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multi-omics profiling identifies a deregulated FUS-MAP1B axis in ALS/FTD-associated UBQLN2 mutants.
    Strohm L; Hu Z; Suk Y; Rühmkorf A; Sternburg E; Gattringer V; Riemenschneider H; Berutti R; Graf E; Weishaupt JH; Brill MS; Harbauer AB; Dormann D; Dengjel J; Edbauer D; Behrends C
    Life Sci Alliance; 2022 Nov; 5(11):. PubMed ID: 35777956
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced PHOX2B stability causes axonal growth impairment in motor neurons with TARDBP mutations.
    Mitsuzawa S; Suzuki N; Akiyama T; Ishikawa M; Sone T; Kawada J; Funayama R; Shirota M; Mitsuhashi H; Morimoto S; Ikeda K; Shijo T; Ohno A; Nakamura N; Ono H; Ono R; Osana S; Nakagawa T; Nishiyama A; Izumi R; Kaneda S; Ikeuchi Y; Nakayama K; Fujii T; Warita H; Okano H; Aoki M
    Stem Cell Reports; 2021 Jun; 16(6):1527-1541. PubMed ID: 34048688
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impairment of Mitochondrial Calcium Buffering Links Mutations in C9ORF72 and TARDBP in iPS-Derived Motor Neurons from Patients with ALS/FTD.
    Dafinca R; Barbagallo P; Farrimond L; Candalija A; Scaber J; Ababneh NA; Sathyaprakash C; Vowles J; Cowley SA; Talbot K
    Stem Cell Reports; 2020 May; 14(5):892-908. PubMed ID: 32330447
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Wild-type and pathogenic forms of ubiquilin 2 differentially modulate components of the autophagy-lysosome pathways.
    Idera A; Sharkey LM; Kurauchi Y; Kadoyama K; Paulson HL; Katsuki H; Seki T
    J Pharmacol Sci; 2023 Jul; 152(3):182-192. PubMed ID: 37257946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Global proteomics of Ubqln2-based murine models of ALS.
    Whiteley AM; Prado MA; de Poot SAH; Paulo JA; Ashton M; Dominguez S; Weber M; Ngu H; Szpyt J; Jedrychowski MP; Easton A; Gygi SP; Kurz T; Monteiro MJ; Brown EJ; Finley D
    J Biol Chem; 2021; 296():100153. PubMed ID: 33277362
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Striking phenotypic variation in a family with the P506S UBQLN2 mutation including amyotrophic lateral sclerosis, spastic paraplegia, and frontotemporal dementia.
    Gkazi SA; Troakes C; Topp S; Miller JW; Vance CA; Sreedharan J; Al-Chalabi A; Kirby J; Shaw PJ; Al-Sarraj S; King A; Smith BN; Shaw CE
    Neurobiol Aging; 2019 Jan; 73():229.e5-229.e9. PubMed ID: 30348461
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mutations in UBQLN2 cause dominant X-linked juvenile and adult-onset ALS and ALS/dementia.
    Deng HX; Chen W; Hong ST; Boycott KM; Gorrie GH; Siddique N; Yang Y; Fecto F; Shi Y; Zhai H; Jiang H; Hirano M; Rampersaud E; Jansen GH; Donkervoort S; Bigio EH; Brooks BR; Ajroud K; Sufit RL; Haines JL; Mugnaini E; Pericak-Vance MA; Siddique T
    Nature; 2011 Aug; 477(7363):211-5. PubMed ID: 21857683
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.